111 Operating Income 2018-2025 | YI

111 operating income from 2018 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
111 Annual Operating Income
(Millions of US $)
2024 $0
2023 $-49
2022 $-54
2021 $-101
2020 $-73
2019 $-71
2018 $-58
2017 $-38
111 Quarterly Operating Income
(Millions of US $)
2025-09-30 $0
2025-06-30 $0
2025-03-31 $0
2024-12-31 $-1
2024-09-30 $0
2024-06-30 $0
2024-03-31 $1
2023-12-31 $-29
2023-09-30 $-11
2023-06-30 $-6
2023-03-31 $-3
2022-12-31 $-14
2022-09-30 $-11
2022-06-30 $-12
2022-03-31 $-16
2021-12-31 $-18
2021-09-30 $-27
2021-06-30 $-29
2021-03-31 $-26
2020-12-31 $-25
2020-09-30 $-18
2020-06-30 $-13
2020-03-31 $-16
2019-12-31 $-24
2019-09-30 $-17
2019-06-30 $-15
2019-03-31 $-16
2018-09-30 $-19
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.068B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $28.272B 32.70
Tempus AI (TEM) United States $9.034B 0.00
IRhythm Holdings (IRTC) United States $4.782B 0.00
Doximity (DOCS) United States $4.652B 19.77
Hims & Hers Health (HIMS) United States $3.597B 29.26
Hinge Health (HNGE) United States $3.107B 0.00
Privia Health (PRVA) United States $2.645B 165.38
10x Genomics (TXG) United States $2.216B 0.00
Heartflow (HTFL) United States $1.915B 0.00
Inspire Medical Systems (INSP) United States $1.733B 23.12
Omnicell (OMCL) United States $1.624B 45.22
Azenta (AZTA) United States $1.295B 52.07
Enovis (ENOV) United States $1.253B 6.58
Clover Health Investments (CLOV) United States $1.044B 0.00
Schrodinger (SDGR) United States $0.833B 0.00
Butterfly Network (BFLY) United States $0.770B 0.00
Phreesia (PHR) United States $0.715B 0.00
Fulgent Genetics (FLGT) United States $0.710B 0.00
Talkspace (TALK) United States $0.626B 126.00
Standard BioTools (LAB) United States $0.427B 0.00
Zepp Health (ZEPP) Netherlands $0.353B 0.00
Claritev (CTEV) United States $0.330B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.321B 0.00
Senseonics Holdings (SENS) United States $0.310B 0.00
Evolent Health (EVH) United States $0.295B 0.00
Carlsmed (CARL) United States $0.286B 0.00
TruBridge (TBRG) United States $0.283B 13.00
CapsoVision (CV) United States $0.221B 0.00
KORU Medical Systems (KRMD) United States $0.202B 0.00
MDxHealth SA (MDXH) Belgium $0.162B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.160B 0.00
Nyxoah SA (NYXH) Belgium $0.149B 0.00
Health Catalyst (HCAT) United States $0.130B 0.00
CareCloud (CCLD) United States $0.100B 5.49
American Well (AMWL) United States $0.071B 0.00
Outset Medical (OM) United States $0.069B 0.00
NetraMark Holdings (AINMF) Canada $0.064B 0.00
Pulmonx (LUNG) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.049B 0.00
Precipio (PRPO) United States $0.039B 0.00
EUDA Health Holdings (EUDA) Singapore $0.027B 0.00
Evaxion - (EVAX) Denmark $0.027B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Lunai Bioworks (LNAI) United States $0.019B 0.00
P3 Health Partners (PIII) United States $0.014B 0.00
Movano (MOVE) United States $0.014B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
ITonic Holdings (ITOC) China $0.007B 0.00
Zhongchao (ZCMD) China $0.006B 0.00
Bullfrog AI Holdings (BFRG) United States $0.005B 0.00
PROFUSA (PFSA) United States $0.004B 0.00
Strata Skin Sciences (SSKN) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00